- Home
- ABVC vs OVID Comparison
ABVC vs OVID Comparison
Compare ABVC & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- OVID
- Stock Information
- Founded
- ABVC 2015
- OVID 2014
- Country
- ABVC United States
- OVID United States
- Employees
- ABVC N/A
- OVID N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- ABVC Health Care
- OVID Health Care
- Exchange
- ABVC Nasdaq
- OVID Nasdaq
- Market Cap
- ABVC 22.1M
- OVID 20.6M
- IPO Year
- ABVC N/A
- OVID 2017
- Fundamental
- Price
- ABVC $3.15
- OVID $0.34
- Analyst Decision
- ABVC
- OVID Strong Buy
- Analyst Count
- ABVC 0
- OVID 4
- Target Price
- ABVC N/A
- OVID $3.13
- AVG Volume (30 Days)
- ABVC 436.6K
- OVID 1.6M
- Earning Date
- ABVC 08-13-2025
- OVID 08-12-2025
- Dividend Yield
- ABVC N/A
- OVID N/A
- EPS Growth
- ABVC N/A
- OVID N/A
- EPS
- ABVC N/A
- OVID N/A
- Revenue
- ABVC $508,383.00
- OVID $548,000.00
- Revenue This Year
- ABVC $735.18
- OVID N/A
- Revenue Next Year
- ABVC N/A
- OVID $5.32
- P/E Ratio
- ABVC N/A
- OVID N/A
- Revenue Growth
- ABVC 1904.43
- OVID 15.61
- 52 Week Low
- ABVC $0.40
- OVID $0.24
- 52 Week High
- ABVC $3.12
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- ABVC 69.63
- OVID 56.68
- Support Level
- ABVC $2.16
- OVID $0.30
- Resistance Level
- ABVC $3.10
- OVID $0.33
- Average True Range (ATR)
- ABVC 0.26
- OVID 0.03
- MACD
- ABVC 0.09
- OVID 0.00
- Stochastic Oscillator
- ABVC 85.29
- OVID 84.62
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.